There is a need for improvement and standardization in larval descriptions for them to become useful not only for identification purposes but also in comparative and phylogenetic studies. Details of the rearing technique and equipment used should be given, the spent female crab and representative larval stages need to be deposited at a national museum and a minimum of five specimens of each stage should be used for meristic and morphometric criteria. Diagnostic features of the carapace, all appendages, abdomen, and other characters that are to be included in a standard larval description are presented with specifications concerning format and sequence of substructures. Typical configurations of larval structures are given and some possible exceptions are described. Guidelines for illustrations including the preparation, size, sequence and arrangement of figures are provided.
1 October 2020 in Science of The Total Environment
DNA samples were extracted from ethanol and formalin-fixed decapod crustacean tissue using a new method based on Tetramethylsilane (TMS)-Chelex. It is shown that neither an indigestible matrix of cross-linked protein nor soluble PCR inhibitors impede PCR success when dealing with formalin-fixed material. Instead, amplification success from formalin-fixed tissue appears to depend on the presence of unmodified DNA in the extracted sample. A staining method that facilitates the targeting of samples with a high content of unmodified DNA is provided.
Paragonimiasis, human lung fluke disease, is a foodborne anthropozoonosis caused by the trematodes assigned toParagonimusand is regarded by the World Health Organization as a Neglected Tropical Disease (NTD). The life cycle of this medically important parasite centres on a complex freshwater biological community that includes two intermediate hosts: a mollusc and a decapod, usually a brachyuran. Although there is a perception that the biology, symptoms, diagnosis and treatment ofParagonimusis well understood, in reality, this is not the case, especially in Africa. Much remains unknown concerning the life-cycle of the parasite, its transmission, the current epidemiology of the disease, diagnosis and the effectiveness of treatment. Furthermore, cases of paragonimiasis may be misdiagnosed as resistant tuberculosis (TB) because of the similar pulmonary symptoms and no remission after anti TB therapy. The endemic foci of human paragonimiasis in Africa have been reported mainly in the forest zones of Upper Guinea (Liberia, Guinea and Ivory Coast) and Lower Guinea (Nigeria, Cameroon, Equatorial Guinea and Gabon). Despite the perceived medical importance of paragonimiasis, relatively little attention has been paid to this NTD since its discovery in Africa in the 1960s. This review focuses on the current understanding of the life cycle and transmission ofParagonimusin Africa, discusses its diagnosis and public health importance and highlights many outstanding gaps in the knowledge that still exist for this NTD.